Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective hydroxamic acid based MMP-12 and MMP-13 inhibitors

Selective hydroxamic acid based MMP-12 and MMP-13 inhibitors

US Patent 8841291 · Granted Sep 23, 2014

Estimated economic value: $18,663,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aminopyridine derivatives and their use as selective ALK-2 inhibitors2025
2-azaspiro[3.4]octane derivatives as M4 agonists2024
2-azaspiro[3.4]octane derivatives as M4 agonists2023
2-azaspiro[3.4]octane derivatives as M4 agonists2023
2-azaspiro[3.4]octane derivatives as M4 agonists2022
Pyridinone derivatives and their use as selective ALK-2 inhibitors2021
Compounds and methods for treating bacterial infections2021
Compounds and compositions for inhibiting the activity of SHP22021
Aminopyridine derivatives and their use as selective ALK-2 inhibitors2021
Beta-lactamase inhibitor compounds2020
Aminopyridine derivatives and their use as selective ALK-2 inhibitors2020
Combination therapy for treatment of resistant bacterial infections2019